These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Flow cytometric analysis of uterine sarcomas.
    Author: Lennart K, Lennart B, Ulf S, Bernard T.
    Journal: Gynecol Oncol; 1994 Dec; 55(3 Pt 1):339-42. PubMed ID: 7835771.
    Abstract:
    Eighty-four women with sarcoma uteri were evaluated on the basis of histopathological examination findings. In 45 of the 84 cases, a flow cytometric measure of DNA content and S-phase fraction was performed. Thirty-seven cases of the 45 were available for estimation of S-phase fraction. The histopathologic examination of paraffin-embedded tumor tissue revealed 44% leiomyosarcomas, 25% homologous mixed mullerian tumors, 17% endometrial stromacell sarcomas, 7% heterologous mixed müllerian tumors, 1% rhabdomyosarcomas, and 6% unclassified sarcomas. Eighty-six percent of the tumors were aneuploid, 14% were peridiploid, and the 5-year survivals were 20 and 60%, respectively. Clinical stage and lymphocytic reaction were found to be good prognostic parameters. Multivariate analysis of 5-year survival adjusted for age at menopause, clinical stage, mitotic frequency, lymphocytic response, and S-phase fraction did not give any further significant prognostic factors.
    [Abstract] [Full Text] [Related] [New Search]